Holder Details Alleged S&P Misleading of Investors

Feb. 5 (Bloomberg) -- U.S. Attorney general Eric Holder details the alleged misleading of investors by Standard & Poor's in the Justice Department's lawsuit against Standard & Poor's, alleging a scheme to defraud investors on RMBS and CDOs.

GlaxoSmithKline CEO on Performance, Products, Growth
02:03 - GlaxoSmithKline CEO Andrew Witty discusses the company's earnings, products, growth and performance. He speaks on "Bloomberg ‹GO›." (Corrects to remove incorrect on-screen graphic) (Source: Bloomberg)
  • GlaxoSmithKline CEO: Strong Currency Tailwind Effect
  • The Mojave: A Journey Into America's Invention Badlands
  • Deutsche Bank Faces Deeper Cuts on Profit Surprise